CY1111835T1 - Δισκιο καθυστερημενης αποδεσμευσης με καθορισμενη γεωμετρια πυρηνα - Google Patents
Δισκιο καθυστερημενης αποδεσμευσης με καθορισμενη γεωμετρια πυρηναInfo
- Publication number
- CY1111835T1 CY1111835T1 CY20111100871T CY111100871T CY1111835T1 CY 1111835 T1 CY1111835 T1 CY 1111835T1 CY 20111100871 T CY20111100871 T CY 20111100871T CY 111100871 T CY111100871 T CY 111100871T CY 1111835 T1 CY1111835 T1 CY 1111835T1
- Authority
- CY
- Cyprus
- Prior art keywords
- coating
- late release
- release disk
- active agent
- core
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Επικαλυμμένο με πρέσα δισκίο που περιλαμβάνει έναν πυρήνα περιέχοντα φαρμακευτική ουσία, και επικάλυψη, ο δε πυρήνας είναι διατιθέμενος εντός της επικάλυψης ούτως ώστε η επικάλυψη να έχει ένα πρώτο πάχος περί του άξονα Α-Β και ένα πάχος περί του ορθογώνιου άξονα Χ-Υ, ούτως ώστε η επικάλυψη περί του άξονα Χ-Υ να είναι παχύτερη από ότι η επικάλυψη περί του άξονα Α-Β, και να προσαρμόζεται για να παράσχει χρόνο υστέρησης μεταξύ περίπου 2 έως 6 ωρών κατά την διάρκεια του οποίου δεν αποδεσμεύεται ουσιαστικώς καμία φαρμακευτική ουσία.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0309342 | 2003-04-24 | ||
EP04729170A EP1631251B1 (en) | 2003-04-24 | 2004-04-23 | Delayed release tablet with defined core geometry |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111835T1 true CY1111835T1 (el) | 2015-10-07 |
Family
ID=33306519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111100871T CY1111835T1 (el) | 2003-04-24 | 2011-09-09 | Δισκιο καθυστερημενης αποδεσμευσης με καθορισμενη γεωμετρια πυρηνα |
Country Status (20)
Country | Link |
---|---|
US (6) | US8168218B2 (el) |
EP (1) | EP1631251B1 (el) |
JP (1) | JP4790597B2 (el) |
KR (1) | KR101192722B1 (el) |
CN (2) | CN1777412A (el) |
AT (1) | ATE512659T1 (el) |
AU (1) | AU2004231362B2 (el) |
BR (1) | BRPI0409652A (el) |
CA (1) | CA2523158C (el) |
CY (1) | CY1111835T1 (el) |
DK (1) | DK1631251T3 (el) |
ES (1) | ES2368066T3 (el) |
IL (1) | IL171494A (el) |
MX (1) | MXPA05011446A (el) |
PL (1) | PL1631251T3 (el) |
PT (1) | PT1631251E (el) |
RU (1) | RU2391093C2 (el) |
SI (1) | SI1631251T1 (el) |
WO (1) | WO2004093843A1 (el) |
ZA (1) | ZA200509477B (el) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030068375A1 (en) | 2001-08-06 | 2003-04-10 | Curtis Wright | Pharmaceutical formulation containing gelling agent |
EP1429739A1 (en) | 2001-09-21 | 2004-06-23 | Egalet A/S | Polymer release system |
WO2003024430A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Morphine polymer release system |
EP1610767B1 (en) | 2003-03-26 | 2011-01-19 | Egalet A/S | Morphine controlled release system |
ATE445393T1 (de) * | 2003-04-24 | 2009-10-15 | Jagotec Ag | Tablette mit gefärbtem kern |
AU2004231362B2 (en) | 2003-04-24 | 2009-11-12 | Jagotec Ag | Delayed release tablet with defined core geometry |
WO2005123039A1 (en) | 2004-06-12 | 2005-12-29 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
DE102004043863A1 (de) | 2004-09-10 | 2006-03-16 | Nitec Pharma Ag | Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum |
JP5161075B2 (ja) * | 2005-06-03 | 2013-03-13 | エガレット エイ/エス | 分散媒体の第1フラクションとマトリックスの第2フラクションを有し、第2フラクションが胃腸の液体に少なくとも部分的に最初に曝される固形の医薬組成物 |
UA91376C2 (ru) * | 2005-08-24 | 2010-07-26 | Рубикон Рисеч Пвт Лтд. | Рецептура с контролируемым высвобождением |
TWI274889B (en) * | 2005-10-06 | 2007-03-01 | Elan Microelectronics Corp | Resistive touch screen measurement system |
MX2009001248A (es) * | 2006-08-03 | 2009-02-11 | Nitec Pharma Ag | Tratamiento con glucocorticoide de liberacion prolongada de enfermedad reumatoide. |
EP2121107B1 (en) * | 2006-12-18 | 2012-10-31 | Eatlittle Inc. | Device for delivery of a substance |
AU2008258596B2 (en) | 2007-06-04 | 2013-02-14 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
US10363221B2 (en) * | 2007-10-17 | 2019-07-30 | I-Property Holding Corp. | Manufacturing solid pharmaceutical dosage forms with visible micro- and nanostructured surfaces and micro- and nanostructured pharmaceutical dosage form |
US20090214599A1 (en) * | 2008-02-21 | 2009-08-27 | Agi Therapeutics Plc | Proton pump inhibitor formulations, and methods of preparing and using such formulations |
AU2010207740B2 (en) * | 2009-01-26 | 2016-06-16 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of asthma |
NZ582836A (en) * | 2009-01-30 | 2011-06-30 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage |
EP2393487B1 (en) | 2009-02-06 | 2016-11-02 | Egalet Ltd. | Pharmaceutical compositions resistant to abuse |
AU2010211220B2 (en) | 2009-02-06 | 2013-08-01 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
AU2010265213B2 (en) | 2009-06-24 | 2012-08-23 | Egalet Ltd. | Controlled release formulations |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
GB201003734D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Delayed prolonged drug delivery |
GB201003766D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Pulsatile drug release |
GB201003731D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
EP2554168B1 (en) | 2010-03-29 | 2018-01-24 | Astellas Pharma Inc. | Controlled release pharmaceutical composition |
WO2012080833A2 (en) | 2010-12-13 | 2012-06-21 | Purdue Pharma L.P. | Controlled release dosage forms |
RS56344B1 (sr) | 2010-12-22 | 2017-12-29 | Purdue Pharma Lp | Obloženi dozni oblici sa kontrolisanim oslobađanjem otporni na zloupotrebu |
CN103327969A (zh) | 2010-12-23 | 2013-09-25 | 普渡制药公司 | 抗篡改固体口服剂型 |
WO2013030726A1 (en) | 2011-08-26 | 2013-03-07 | Wockhardt Limited | Programmed drug delivery |
RU2471479C1 (ru) * | 2012-02-13 | 2013-01-10 | Общество с ограниченной ответственностью "Агентство редких лекарств и технологий" | Фармацевтическая композиция в форме таблетки для перорального введения, содержащая в качестве активного компонента дексаметазон, и способ ее получения |
US20130243861A1 (en) * | 2012-03-16 | 2013-09-19 | Cadila Healthcare Limited | Press-coated tablets of prednisone |
JP5818219B2 (ja) * | 2012-05-14 | 2015-11-18 | 塩野義製薬株式会社 | 6,7−不飽和−7−カルバモイルモルヒナン誘導体含有製剤 |
PL2854769T3 (pl) * | 2012-07-05 | 2023-08-07 | Taiwan Liposome Company, Ltd. | Sposoby leczenia zapalenia stawów |
KR20150059167A (ko) | 2012-07-06 | 2015-05-29 | 에갈렛 리미티드 | 제어된 방출을 위한 남용 제지 약학적 조성물 |
CN105120846B (zh) | 2013-02-05 | 2019-10-18 | 普渡制药公司 | 抗篡改的药物制剂 |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
GB201420311D0 (en) | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Pharmaceutical processing |
GB201420306D0 (en) | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Compositions |
WO2016114726A1 (en) * | 2015-01-12 | 2016-07-21 | Ilko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Time-controlled prednisone delayed release tablet |
US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
CA3047325A1 (en) * | 2016-12-21 | 2018-06-28 | Tioga Pharmaceuticals Inc. | Solid pharmaceutical formulations of asimadoline |
CN114588124B (zh) * | 2020-12-07 | 2023-10-20 | 江苏恒瑞医药股份有限公司 | 一种延迟释放的药物组合物 |
WO2023102491A1 (en) * | 2021-12-01 | 2023-06-08 | Invea Therapeutics, Inc. | Methods for treating gastrointestinal inflammatory disease |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB874586A (en) | 1957-10-28 | 1961-08-10 | Upjohn Co | Improvements in or relating to therapeutic compositions and the manufacture thereof |
US3870790A (en) | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
GB8518301D0 (en) | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
GB8705083D0 (en) | 1987-03-04 | 1987-04-08 | Euro Celtique Sa | Spheroids |
JP2558396B2 (ja) | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
DE59005781D1 (de) | 1990-07-02 | 1994-06-23 | Boehringer Mannheim Gmbh | Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit. |
IE61651B1 (en) | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
WO1992011845A1 (en) | 1991-01-03 | 1992-07-23 | Glaxo Canada Inc. | Method for production of solid pharmaceutical preparation |
DE4100920A1 (de) * | 1991-01-15 | 1992-07-16 | Degussa | Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer |
AU3949093A (en) | 1992-03-31 | 1993-11-08 | Benzon Pharma A/S | A pharmaceutical formulation |
JPH07507564A (ja) | 1992-09-30 | 1995-08-24 | ファイザー・インク. | コア及び厚さが一定でないコーティングを含有する物品 |
WO1994008589A1 (en) | 1992-10-09 | 1994-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
US5482718A (en) | 1994-03-23 | 1996-01-09 | Hoffmann-La Roche Inc. | Colon-targeted delivery system |
US5464633A (en) * | 1994-05-24 | 1995-11-07 | Jagotec Ag | Pharmaceutical tablets releasing the active substance after a definite period of time |
US5567969A (en) * | 1995-04-20 | 1996-10-22 | Hall; John H. | Compound modulated integrated transistor structure with reduced bipolar switch back effect |
US5811388A (en) | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
JP3220373B2 (ja) | 1995-11-28 | 2001-10-22 | バイエル薬品株式会社 | 持続性ニフエジピン製剤 |
HRP970493A2 (en) | 1996-09-23 | 1998-08-31 | Wienman E. Phlips | Oral delayed immediate release medical formulation and method for preparing the same |
US5792476A (en) * | 1996-12-19 | 1998-08-11 | Abigo Medical Ab | Sustained release glucocorticoid pharmaceutical composition |
HUP0002296A3 (en) | 1997-07-01 | 2001-11-28 | Pfizer | Sertraline salts and sustained-release dosage forms of sertraline |
US6013280A (en) * | 1997-10-07 | 2000-01-11 | Fuisz Technologies Ltd. | Immediate release dosage forms containing microspheres |
KR20010031034A (ko) | 1997-10-09 | 2001-04-16 | 페리오 프로덕츠 리미티드 | 전체 방출을 지연시키는 위장의 약물 송달 시스템 |
US6365185B1 (en) * | 1998-03-26 | 2002-04-02 | University Of Cincinnati | Self-destructing, controlled release peroral drug delivery system |
EP1067910B1 (en) | 1998-04-03 | 2004-05-26 | Egalet A/S | Controlled release composition |
US6602521B1 (en) | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
EP1027888B1 (en) | 1999-02-10 | 2009-06-10 | Pfizer Products Inc. | Osmotic system for delivery of solid amorphous dispersions of drugs |
GB9905898D0 (en) * | 1999-03-15 | 1999-05-05 | Darwin Discovery Ltd | Controlled-dose formulation |
US6245352B1 (en) * | 1999-04-27 | 2001-06-12 | Eli Lilly And Company | Pharmaceutical formulation |
JP2001010950A (ja) | 1999-06-29 | 2001-01-16 | Taiyo Yakuhin Kogyo Kk | 安定で良好な薬物放出を有する医薬組成物 |
EP1074249A1 (en) | 1999-07-27 | 2001-02-07 | Jagotec Ag | A pharmaceutical tablet system for releasing at least one active substance during a release period subsequent to a no-release period |
AR026148A1 (es) * | 2000-01-21 | 2003-01-29 | Osmotica Argentina S A | Dispositivo osmotico con pasaje preformado que aumenta de tamano |
DE10012555A1 (de) | 2000-03-15 | 2001-09-20 | Merck Patent Gmbh | Glucocorticoide in einer Modified Release-Formulierung |
US20020028240A1 (en) | 2000-04-17 | 2002-03-07 | Toyohiro Sawada | Timed-release compression-coated solid composition for oral administration |
AU2001247887A1 (en) | 2000-04-19 | 2001-11-07 | Eurand America Inc. | Dual mechanism timed release dosage forms for low dose drugs |
US6476006B2 (en) * | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
US6720005B1 (en) | 2000-07-07 | 2004-04-13 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Coated, platform-generating tablet |
US6620439B1 (en) * | 2000-10-03 | 2003-09-16 | Atul M. Mehta | Chrono delivery formulations and method of use thereof |
HUP0501071A3 (en) * | 2001-03-13 | 2007-06-28 | Penwest Pharmaceutical Co | Chronotherapeutic dosage forms |
NZ532568A (en) | 2001-09-28 | 2005-07-29 | Mcneil Ppc Inc | Modified release dosage forms |
KR20040091135A (ko) | 2002-03-14 | 2004-10-27 | 다이이찌 산토리 파마 가부시키가이샤 | 염산 필지카이니드 함유 정제(건식) |
EP1545472B1 (en) | 2002-09-28 | 2010-12-08 | McNeil-PPC, Inc. | Modified release dosage forms with two cores and an opening |
ATE445393T1 (de) | 2003-04-24 | 2009-10-15 | Jagotec Ag | Tablette mit gefärbtem kern |
AU2004231362B2 (en) * | 2003-04-24 | 2009-11-12 | Jagotec Ag | Delayed release tablet with defined core geometry |
UY28326A1 (es) | 2003-05-22 | 2004-06-30 | Osmotica Argentina S A | Dispositivo de ruptura de liberacion controlada con un pasaje preformado |
US8029822B2 (en) * | 2003-05-22 | 2011-10-04 | Osmotica Kereskedelmi és Seolgáltató KFT | Rupturing controlled release device having a preformed passageway |
US20050118267A1 (en) | 2003-09-19 | 2005-06-02 | Penwest Pharmaceuticals Co. | Chronotherapeutic dosage forms |
DE102004043863A1 (de) * | 2004-09-10 | 2006-03-16 | Nitec Pharma Ag | Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum |
-
2004
- 2004-04-23 AU AU2004231362A patent/AU2004231362B2/en not_active Expired
- 2004-04-23 SI SI200431744T patent/SI1631251T1/sl unknown
- 2004-04-23 KR KR1020057020196A patent/KR101192722B1/ko active Protection Beyond IP Right Term
- 2004-04-23 CN CNA2004800110504A patent/CN1777412A/zh active Pending
- 2004-04-23 BR BRPI0409652-5A patent/BRPI0409652A/pt not_active Application Discontinuation
- 2004-04-23 WO PCT/IB2004/001693 patent/WO2004093843A1/en active Application Filing
- 2004-04-23 AT AT04729170T patent/ATE512659T1/de active
- 2004-04-23 EP EP04729170A patent/EP1631251B1/en not_active Expired - Lifetime
- 2004-04-23 MX MXPA05011446A patent/MXPA05011446A/es active IP Right Grant
- 2004-04-23 JP JP2006506623A patent/JP4790597B2/ja not_active Expired - Lifetime
- 2004-04-23 DK DK04729170.3T patent/DK1631251T3/da active
- 2004-04-23 PL PL04729170T patent/PL1631251T3/pl unknown
- 2004-04-23 CN CN201210029664.1A patent/CN102525993B/zh not_active Expired - Fee Related
- 2004-04-23 RU RU2005132451/15A patent/RU2391093C2/ru not_active IP Right Cessation
- 2004-04-23 US US10/554,538 patent/US8168218B2/en active Active
- 2004-04-23 PT PT04729170T patent/PT1631251E/pt unknown
- 2004-04-23 CA CA2523158A patent/CA2523158C/en not_active Expired - Lifetime
- 2004-04-23 ES ES04729170T patent/ES2368066T3/es not_active Expired - Lifetime
-
2005
- 2005-10-20 IL IL171494A patent/IL171494A/en not_active IP Right Cessation
- 2005-11-23 ZA ZA200509477A patent/ZA200509477B/xx unknown
-
2011
- 2011-09-09 CY CY20111100871T patent/CY1111835T1/el unknown
-
2012
- 2012-03-19 US US13/424,069 patent/US8309124B2/en not_active Expired - Lifetime
- 2012-03-23 US US13/428,548 patent/US8394407B2/en not_active Expired - Lifetime
- 2012-12-13 US US13/713,528 patent/US9186332B2/en not_active Expired - Lifetime
-
2014
- 2014-07-11 US US14/329,631 patent/US9040085B2/en not_active Expired - Lifetime
-
2015
- 2015-10-07 US US14/877,305 patent/US9884021B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111835T1 (el) | Δισκιο καθυστερημενης αποδεσμευσης με καθορισμενη γεωμετρια πυρηνα | |
ME00391B (me) | Tableta bupropion hidrohlorida sa modifikovanim otpuštanjem | |
ATE455538T1 (de) | Retardtabletten mit hydromorphon | |
ATE268593T1 (de) | Bupropionhydrochlorid enthaltende tabletten mit gesteuerter wirkstoffabgabe | |
WO2003026626A3 (en) | Modified release dosage forms | |
UA88509C2 (ru) | Сублингвальная таблетка с покрытием, которое содержит опиоидный анальгетик | |
EA200600598A1 (ru) | Лекарственные формы замедленного высвобождения | |
DK0779807T3 (da) | Fremgangsmåde til fremstilling af en kappetablet med spids kerne | |
AU2002254036A1 (en) | Taste masked pharmaceutical compositions | |
NO20035655L (no) | Fremgangsmate for fremstilling av tabletter | |
PE20001304A1 (es) | Preparado farmaceutico de moxifloxacina | |
WO2007072495A3 (en) | Coated tablets having prolonged gastric retention | |
NO20042822L (no) | Forlenget frigjoring - farmasoytisk tablett av metformin | |
BRPI0412697A (pt) | composições farmacêuticas que apresentam um revestimento expansìvel | |
CA2543353A1 (en) | Oral drug delivery system | |
DE60321801D1 (de) | Sphäroide, deren herstellungsverfahren und sphäroidenhaltige arzneimittel | |
AUPR098400A0 (en) | Production of radionuclide coated microspheres and seeds | |
EA200800966A1 (ru) | Новая композиция, содержащая росиглитазон и другое противодиабетическое средство | |
ATE485814T1 (de) | Magnesium-mikrotabletten mit verzögerter freisetzung | |
HUP0102788A2 (hu) | Ciklofoszfamid filmtabletták és eljárás az előállításukra | |
DE60002089D1 (de) | Niedrig dosierte tabletten, und verfahren zur herstellung | |
ATE392644T1 (de) | Alpha-(1' -hydroxyalkyl)acrylate enthaltende beschichtungsmassen | |
DK1280526T3 (da) | Anvendelse af 2-iminobiotin til fremstilling af et lægemiddel til forebyggelse og/eller behandling af komplikationer hos nyfödte som er opstået under födslen | |
DE50303646D1 (de) | Feste pharmazeutische Zusammensetzung enthaltend Tilidinhydrochlorid | |
AR033431A1 (es) | Composiciones farmaceuticas de sabor enmascarado. |